Stem Cells

  • A Stanford Medicine-led study found that residual liver cancer cells interact with neighboring macrophages to prompt the disease to reappear.

  • Lymphoma therapy shows promise

    In an early Stanford Medicine study, CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy’s molecular target improved response.

  • Chuck Chan dies at 48

    The Stanford Medicine researcher was known for his groundbreaking work and his generous spirit as a mentor and colleague.

  • Two elected to National Academy of Medicine

    Bonnie Maldonado and Kristy Red-Horse join distinguished society of physicians.

  • Stem cell therapy with Alzheimer’s

    In a Stanford Medicine study, scientists transplanted stem cells into mice and found reduction of brain abnormalities typical of Alzheimer’s disease.

  • Antibody treatment rejuvenates stem cells

    Old muscle stem cells express high levels of the cancer-associated molecule CD47. Blocking a pathway mediated by CD47 restored strength to old mice in a Stanford Medicine study.

  • Step toward growing organs

    Researchers have shown initial viability of an embryo that contains both chimpanzee and macaque cells in a preliminary study that explores the feasibility of primate organ genesis.

  • Immunosuppression-free kidney transplant

    Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.

  • Ketogenic diet helps cells survive stress

    Muscle stem cells enter a deep resting state during fasting or when fed a high-fat ketogenic diet, a Stanford-led study finds. This promotes stem cell resilience but slows injury repair.

  • Electric current aids stroke recovery

    Stanford scientists have developed a device that delivers and electrically stimulates stem cells to promote stroke healing.

  • $12 million for stem cell trial

    Stanford researcher Maria Grazia Roncarolo has been awarded $12 million by the California Institute for Regenerative Medicine for a trial aimed at improving the outcomes of stem cell transplants in children and young adults with blood cancers.

  • $31 million for stem cell clinical trials

    The California Institute for Regenerative Medicine has awarded $31 million to three Stanford researchers to launch trials of treatments for common diseases. Four other Stanford researchers also received a total of $4.55 million.


Related Websites